Sign in

CIK 0001041024

  • Non-accelerated filer
  • Smaller reporting company

ROCKWELL MEDICAL, INC.

Sign in to watch
Ticker
RMTI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
383317208
Phone
+1 800-449-3353
Business address
30142 WIXOM ROAD, WIXOM, MI, 48393
Former names
ROCKWELL MEDICAL TECHNOLOGIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$8,420
in 1 filing, $8K under 10b5-1 plans

Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Strobeck Mark −$8K President and CEO sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-06-13 BOYD RONALD D Director Other disposition · Stock option (right to buy) −25,000 25,000
2013-06-13 BOYD RONALD D Director Other disposition · Stock option (right to buy) −12,500 12,500
2013-06-13 BOYD RONALD D Director Other disposition · Stock option (right to buy) −12,500 12,500
2013-06-13 BOYD RONALD D Director Other disposition · Stock option (right to buy) −8,334 8,333
2013-06-13 BOYD RONALD D Director Other disposition · Stock option (right to buy) −8,333 8,334
2013-06-13 BOYD RONALD D Director Other disposition · Stock option (right to buy) −8,333 8,334
2013-02-08 HOLT KENNETH L Director Exercise or conversion +25,000 $3.06 $77K 32,900
2013-02-08 HOLT KENNETH L Director Shares withheld for taxes −13,986 $5.47 $77K 18,914
2013-02-08 HOLT KENNETH L Director Exercise or conversion +10,000 $4.05 $41K 28,914
2013-02-08 HOLT KENNETH L Director Shares withheld for taxes −7,405 $5.47 $41K 21,509
2013-02-08 HOLT KENNETH L Director Exercise or conversion · Stock option (right to buy) −25,000 0
2013-02-08 HOLT KENNETH L Director Exercise or conversion · Stock option (right to buy) −10,000 0
2013-01-31 HOLT KENNETH L Director Grant or award · Stock Option (right to buy) +25,000 25,000
2013-01-31 BOYD RONALD D Director Grant or award · Stock Option (right to buy) +25,000 25,000
2013-01-31 Bagley Patrick J Director Grant or award · Stock Option (right to buy) +25,000 25,000
2013-01-31 KLEMA THOMAS E Vice President, CFO Grant or award · Stock Option (right to buy) +100,000 100,000
2013-01-31 Pratt Raymond Dennis VP of Drug Development Grant or award · Stock Option (right to buy) +150,000 150,000
2013-01-31 Gupta Ajay Chief Scientific Officer Grant or award · Stock Option (right to buy) +150,000 150,000
2013-01-31 CHIOINI ROBERT L Chairman, President and CEO Grant or award · Stock Option (right to buy) +250,000 250,000
2013-01-28 HAGELSTEIN DAVID A 10% owner Other disposition · Common Stock Warrant −862,502 0

Page 26 of 30 · 588 trades